About Gene Solutions
Gene Solutions is a private company based in Charlottesville, Virginia. It has reported $6,339,800 raised in five offerings on Form D since February 2013.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 12, 2018 | Dec 26, 2018amended Jun 3, 2024 | $5,330,000fully sold | 12 | $444K | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Aug 1, 2017 | Aug 17, 2017 | $65,000of $250K target | 5 | $13,000 | Convertible promissory note for Company's Series A Preferred Units.Rule 506(b) | Form D ↗ |
| Sep 29, 2015 | Oct 2, 2015 | $639,800of $700K target | 2 | $319K | EquityRule 506(b) | Form D ↗ |
| Dec 1, 2012 | Feb 25, 2013 | $298,000of $558K target | 3 | $99,333 | Equity06 | Form D ↗ |
| Nov 7, 2011 | Feb 25, 2013 | $7,000of $265K target | 2 | $3,500 | Equity06 | Form D ↗ |
| Total, five offerings | $6,339,800 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gene Solutions's Form D filed Jun 3, 2024.
DP
David Patteson
Executive officer and director
JO
James Oury
Director
EC
Edward Connell
CFO and director
SJ
Susan Jones
Executive officer and director
Earlier filings also listed W. Parker, Jr. (executive officer and director, last listed Aug 2017), Brian Warrington (executive officer and director, last listed Aug 2017) and James Powers (director, last listed Feb 2013).